These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 15809743

  • 1. Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells.
    Sugiyama M, Imai A, Furui T, Tamaya T.
    Oncol Rep; 2005 May; 13(5):813-7. PubMed ID: 15809743
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Independent action of serine/threonine protein phosphatase in ovarian cancer plasma membrane and cytosol during gonadotropin-releasing hormone stimulation.
    Sugiyama M, Imai A, Furui T, Tamaya T.
    Oncol Rep; 2003 May; 10(6):1885-9. PubMed ID: 14534713
    [Abstract] [Full Text] [Related]

  • 4. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S, Schlotawa L, Günthert AR, Emons G, Gründker C.
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase.
    Boudreau RT, Conrad DM, Hoskin DW.
    Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342
    [Abstract] [Full Text] [Related]

  • 6. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y, Varol U, Atmaca H, Kisim A, Sezgin C, Karabulut B, Uzunoglu S, Uslu R, Karaca B.
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [Abstract] [Full Text] [Related]

  • 7. Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells.
    Imai A, Iida K, Furui T, Tamaya T.
    Int J Oncol; 2002 May; 20(5):987-92. PubMed ID: 11956594
    [Abstract] [Full Text] [Related]

  • 8. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
    So WK, Cheng JC, Poon SL, Leung PC.
    FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
    [Abstract] [Full Text] [Related]

  • 9. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S, Günthert AR, Emons G, Gründker C.
    Cancer Res; 2007 Feb 15; 67(4):1750-6. PubMed ID: 17308117
    [Abstract] [Full Text] [Related]

  • 11. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
    Chen L, Liu L, Yin J, Luo Y, Huang S.
    Int J Biochem Cell Biol; 2009 Jun 15; 41(6):1284-95. PubMed ID: 19038359
    [Abstract] [Full Text] [Related]

  • 12. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA, Howitt IJ, Ackland SP, McCluskey A.
    Cancer Chemother Pharmacol; 2004 Mar 15; 53(3):225-32. PubMed ID: 14648018
    [Abstract] [Full Text] [Related]

  • 13. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S, Günthert AR, Aicher B, Paulini KW, Emons G, Gründker C.
    Cancer Res; 2009 Aug 15; 69(16):6473-81. PubMed ID: 19638591
    [Abstract] [Full Text] [Related]

  • 14. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM, Cheng JC, Wang HS, Huang HY, MacCalman CD, Leung PC.
    Cancer Res; 2009 May 15; 69(10):4202-8. PubMed ID: 19366794
    [Abstract] [Full Text] [Related]

  • 15. Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.
    Imai A, Sugiyama M, Furui T, Tamaya T, Ohno T.
    Gynecol Obstet Invest; 2007 May 15; 63(2):102-6. PubMed ID: 17028438
    [Abstract] [Full Text] [Related]

  • 16. Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation.
    Rao RK, Clayton LW.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):610-6. PubMed ID: 12054646
    [Abstract] [Full Text] [Related]

  • 17. Lithium inhibits ceramide- and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis.
    Chen CL, Lin CF, Chiang CW, Jan MS, Lin YS.
    Mol Pharmacol; 2006 Aug 26; 70(2):510-7. PubMed ID: 16682503
    [Abstract] [Full Text] [Related]

  • 18. Potential involvement of serine/threonine protein phosphatases in apoptosis of HepG2 cells during selenite treatment.
    Celik HA, Kircelli F, Saydam G, Aydin HH.
    Biol Trace Elem Res; 2007 Aug 26; 117(1-3):65-75. PubMed ID: 17873393
    [Abstract] [Full Text] [Related]

  • 19. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
    Günthert AR, Gründker C, Hollmann K, Emons G.
    Biochem Biophys Res Commun; 2002 May 31; 294(1):11-5. PubMed ID: 12054733
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M, Sánchez C, Benitez DA, Contreras HR, Huidobro C, Cabezas J, Acevedo C, Castellón EA.
    Prostate; 2009 Jul 01; 69(10):1025-33. PubMed ID: 19301301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.